Vitamin A & Vitamin D Ointment
- Manufacturer
- E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
- Effective date
- 2012-09-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:45:59
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient:
White Petrolatum (929.3 mg)
Purpose:
Emollient
INDICATIONS & USAGE SECTION
Uses:
- first aid in
- minor burns
- scalds
- sunburn
- windburn
- diaper rash
- chafing
- chapped skin
- nipple care
- abrasions
- cuts
- ulcers
WARNINGS SECTION
Warnings:
For external use only.
Ask doctor before use if you have severe or extensive burns.
When using this product the treatment of ulcers, severe cuts or wounds should be under the direction of a doctor.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
- cleanse affected area with mild soap and warm water
- dry thoroughly
- apply Vitamin A & Vitamin D ointment in a thin layer to the affected area directly to the skin or by spreading on sterile gauze or clean cloth
- bandage loosely
SPL UNCLASSIFIED SECTION
Other information:
- do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal
- store at room temperature
- see crimp of tube for Lot Number and Exp. Date
Inactive Ingredients
fragrance, lanolin, paraffin, vitamin A (as palmitate), vitamin D
SPL UNCLASSIFIED SECTION
Questions or comments? call toll free 1-800-645-9833
E. FOUGERA & CO.
A division of Fougera Pharmaceuticals Inc.
Melville, NY 11747
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – CARTON
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – CARTON
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – CONTAINER
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0168-0035-01 | GM - Gram | 0168-0035 | 7bbb4226-b1cb-489f-b9b2-6ebb84b36e4e | 1 | 2013-02-13 |
| 0168-0035-04 | GM - Gram | 0168-0035 | 3d1e8cf5-34ec-4f18-864c-c7daeb5273de | 1 | 2013-02-13 |
| 0168-0035-16 | GM - Gram | 0168-0035 | befb0940-7f94-40fc-9914-2542f671804d | 1 | 2013-02-13 |
| 0168-0035-45 | GM - Gram | 0168-0035 | fa4e014a-ae91-44bf-a9a5-30e4e34a496a | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PETROLATUM | ACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| PETROLATUM | ACTIVE MOIETY | 4T6H12BN9U | 2 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 2 | |
| PARAFFIN | INACTIVE INGREDIENT | I9O0E3H2ZE | 2 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 | |
| VITAMIN D | INACTIVE INGREDIENT | 9VU1KI44GP | 2 |
Products#
Every source-derived product name is available through these pages.
- Vitamin A and Vitamin D
- PETROLATUM
- LANOLIN
- PARAFFIN
- VITAMIN A PALMITATE
- VITAMIN D
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0168-0035 | 0168-0035-01, 0168-0035-02, 0168-0035-04, 0168-0035-45, 0168-0035-16 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PETROLATUM | 4T6H12BN9U | ACTIB |
| LANOLIN | 7EV65EAW6H | IACT |
| PARAFFIN | I9O0E3H2ZE | IACT |
| VITAMIN A PALMITATE | 1D1K0N0VVC | IACT |
| VITAMIN D | 9VU1KI44GP | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CAPSULE, EXTENDED RELEASE / ORAL | 100 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | EMULSION / TOPICAL | 0.25 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET / ORAL | 0.7 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, EXTENDED RELEASE / ORAL | 321 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SOAP / TOPICAL | 0.4 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SUSPENSION / TOPICAL | 11726 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, COATED / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | AEROSOL, FOAM / TOPICAL | 14235 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / RECTAL | 38 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CREAM / TOPICAL | 300 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, DELAYED RELEASE / ORAL | 0.2 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4af8584f-f458-4947-9840-e0fdcbf0a13c | b43b9b0d-66d0-4011-b44a-f1fe4adf1ec1 | 2021-09-22 | Warnings | b43b9b0d-66d0-4011-b44a-f1fe4adf1ec1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




